IBRX vs. QQQ
Compare and contrast key facts about ImmunityBio, Inc. (IBRX) and Invesco QQQ (QQQ).
QQQ is a passively managed fund by Invesco that tracks the performance of the NASDAQ-100 Index. It was launched on Mar 10, 1999.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IBRX or QQQ.
Key characteristics
| IBRX | QQQ | |
|---|---|---|
| YTD Return | -3.78% | 25.63% |
| 1Y Return | 33.06% | 33.85% |
| 3Y Return (Ann) | -14.51% | 9.83% |
| 5Y Return (Ann) | 34.56% | 21.21% |
| Sharpe Ratio | 0.36 | 2.12 |
| Sortino Ratio | 1.40 | 2.79 |
| Omega Ratio | 1.17 | 1.38 |
| Calmar Ratio | 0.44 | 2.71 |
| Martin Ratio | 1.15 | 9.88 |
| Ulcer Index | 35.23% | 3.72% |
| Daily Std Dev | 111.21% | 17.31% |
| Max Drawdown | -97.14% | -82.98% |
| Current Drawdown | -88.57% | -0.37% |
Correlation
The correlation between IBRX and QQQ is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
IBRX vs. QQQ - Performance Comparison
In the year-to-date period, IBRX achieves a -3.78% return, which is significantly lower than QQQ's 25.63% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
IBRX vs. QQQ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ImmunityBio, Inc. (IBRX) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IBRX vs. QQQ - Dividend Comparison
IBRX has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.59%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBRX ImmunityBio, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QQQ Invesco QQQ | 0.59% | 0.62% | 0.80% | 0.43% | 0.55% | 0.74% | 0.91% | 0.84% | 1.06% | 0.99% | 1.41% | 1.02% |
Drawdowns
IBRX vs. QQQ - Drawdown Comparison
The maximum IBRX drawdown since its inception was -97.14%, which is greater than QQQ's maximum drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for IBRX and QQQ. For additional features, visit the drawdowns tool.
Volatility
IBRX vs. QQQ - Volatility Comparison
ImmunityBio, Inc. (IBRX) has a higher volatility of 39.69% compared to Invesco QQQ (QQQ) at 4.91%. This indicates that IBRX's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.